Alkermes plc (ALKS)
NASDAQ: ALKS · IEX Real-Time Price · USD
24.83
+0.18 (0.73%)
At close: Jul 19, 2024, 4:00 PM
24.77
-0.06 (-0.24%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Alkermes Market Cap
Alkermes has a market cap or net worth of $4.20 billion as of July 22, 2024. Its market cap has decreased by -15.83% in one year.
Market Cap
4.20B
Enterprise Value
3.83B
1-Year Change
-15.83%
Ranking
Category
Stock Price
$24.83
Market Cap Chart
Since December 1, 1998, Alkermes's market cap has increased from $383.70M to $4.20B, an increase of 995.06%. That is a compound annual growth rate of 9.78%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 4.20B | -9.23% |
Dec 29, 2023 | 4.63B | 7.82% |
Dec 30, 2022 | 4.29B | 14.15% |
Dec 31, 2021 | 3.76B | 18.47% |
Dec 31, 2020 | 3.18B | -1.20% |
Dec 31, 2019 | 3.21B | -29.92% |
Dec 31, 2018 | 4.59B | -45.52% |
Dec 29, 2017 | 8.42B | -0.36% |
Dec 30, 2016 | 8.45B | -29.09% |
Dec 31, 2015 | 11.91B | 39.10% |
Dec 31, 2014 | 8.56B | 53.99% |
Dec 31, 2013 | 5.56B | 127.59% |
Dec 31, 2012 | 2.44B | 8.61% |
Dec 30, 2011 | 2.25B | 91.59% |
Dec 31, 2010 | 1.17B | 31.68% |
Dec 31, 2009 | 891.70M | -12.16% |
Dec 31, 2008 | 1.02B | -36.29% |
Dec 31, 2007 | 1.59B | 18.17% |
Dec 29, 2006 | 1.35B | -22.92% |
Dec 30, 2005 | 1.75B | 37.76% |
Dec 31, 2004 | 1.27B | 5.23% |
Dec 31, 2003 | 1.21B | 197.29% |
Dec 31, 2002 | 405.90M | -76.06% |
Dec 31, 2001 | 1.70B | -2.38% |
Dec 29, 2000 | 1.74B | 39.28% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
RadNet | 4.58B |
Haemonetics | 4.52B |
Avidity Biosciences | 4.32B |
Inspire Medical Systems | 4.27B |
Integer Holdings | 4.23B |
Crinetics Pharmaceuticals | 4.15B |
Immunovant | 4.09B |
Dyne Therapeutics | 4.06B |